Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Germline alteration by gene therapy: assessing and reducing the risks

J W Gordon1

  • 1Dept of Neurobiology, Mt. Sinai Medical Center, New York, NY 10029, USA. jgordon@smtplink.mssm.edu

Molecular Medicine Today
|December 19, 1998
PubMed
Summary

Gene therapy advancements may lead to germline DNA integration concerns in patients desiring children post-treatment. Further research and vector testing are crucial to assess and mitigate this reproductive risk.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pilot Study of Hyperpolarized <sup>13</sup>C Metabolic Imaging in Pediatric Patients with Diffuse Intrinsic Pontine Glioma and Other CNS Cancers.

AJNR. American journal of neuroradiology·2020
Same author

Dicarboxylic acids as pH sensors for hyperpolarized <sup>13</sup>C magnetic resonance spectroscopic imaging.

The Analyst·2017
Same author

A conserved MADS-box phosphorylation motif regulates differentiation and mitochondrial function in skeletal, cardiac, and smooth muscle cells.

Cell death & disease·2015
Same author

Direct interaction between myocyte enhancer factor 2 (MEF2) and protein phosphatase 1alpha represses MEF2-dependent gene expression.

Molecular and cellular biology·2009
Same author

Seminiferous tubule cannulation (STC): a new, sensitive technique for detecting gene transfer in developing sperm.

Gene therapy·2003
Same author

Editor's commentary: loose use of the phrase "germline genetic modification".

The Journal of experimental zoology·2001

Area of Science:

  • Reproductive biology
  • Gene therapy vectorology
  • Genetics

Background:

  • Gene therapy is increasingly used for various diseases.
  • Patients undergoing gene therapy may desire children post-treatment.
  • Concerns exist regarding potential germline integration of gene therapy vectors.

Purpose of the Study:

  • To evaluate the risk of gene therapy vector DNA integrating into germ cells.
  • To address concerns about reproductive safety following gene therapy.
  • To determine the necessity of specific testing for germline integration potential.

Main Methods:

  • Review of current understanding of reproductive biology.
  • Analysis of gene therapy vector biodistribution data.
  • Recommendation for animal experiments and clinical studies.

Related Experiment Videos

  • Proposal for testing gene therapy vectors for germ cell integration potential.

    • Main Results:

    • Current data suggests a low risk of germline integration.
    • Risk is based on reproductive biology and vector biodistribution.
    • Specific studies are needed to confirm the low risk.
    • Testing for germline integration is recommended for all vectors.

    Conclusions:

    • While the risk appears low, further investigation is warranted.
    • Gene therapy vector DNA integration into germ cells requires careful evaluation.
    • All gene therapy vectors should be tested for their potential to affect germ cells and embryos.